Exozymes (EXOZ) Common Equity (2023 - 2026)
Exozymes (EXOZ) posted quarterly Common Equity of $3.4 million for Q4 2025, down 67.4% year-over-year from $10.4 million in Q4 2024, and down 36.79% quarter-over-quarter from $5.4 million in Q3 2025.
Exozymes (EXOZ) Common Equity (2023 - 2026) Analysis & Trends
Exozymes (EXOZ) has reported Common Equity for 3 consecutive years, with $3.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Common Equity fell 67.4% year-over-year to $3.4 million; the TTM figure through Dec 2025 stood at $3.4 million (down 67.4% YoY), while the FY2025 annual figure was $3.4 million, down 67.4% from the prior year.
- Common Equity retreated to $3.4 million in Q4 2025 per EXOZ's latest filing, from $5.4 million in the prior quarter.
- Across five years, Common Equity topped out at $10.4 million in Q4 2024 and bottomed at -$3.6 million in Q3 2024.
- Historically, Common Equity has averaged $2.8 million across 3 years, with a median of $2.0 million in 2023.
- On a YoY basis, Common Equity climbed as much as 2811.49% in 2024 and fell as far as 693.16% in 2024.
- Exozymes' Common Equity stood at -$384319.0 in 2023, then jumped by 2811.49% to $10.4 million in 2024, then sank by 67.4% to $3.4 million in 2025.
- Business Quant data shows EXOZ's Common Equity at $3.4 million in Q4 2025, $5.4 million in Q3 2025, and $7.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.35 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 757.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.79 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 22.38 Bn |
| 10 | Exozymes | 61.53 Mn | 61.53 Mn | - | 3.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.65 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | 7.24 Mn |
| Mar 31, 2025 | 8.88 Mn |
| Dec 31, 2024 | 10.42 Mn |
| Sep 30, 2024 | -3.60 Mn |
| Jun 30, 2024 | -2.26 Mn |
| Mar 31, 2024 | -1.25 Mn |
| Dec 31, 2023 | -384,319.00 |
| Sep 30, 2023 | 607,141.00 |